Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Insmed (INSM) Operating Margin (2018 - 2026)

Insmed's Operating Margin history spans 12 years, with the latest figure at 50.11% for Q1 2026.

  • Quarterly Operating Margin rose 21722.0% to 50.11% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 140.56% through Mar 2026, up 11687.0% year-over-year, with the annual reading at 205.59% for FY2025, 3588.0% up from the prior year.
  • Operating Margin came in at 50.11% for Q1 2026, up from 121.19% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 50.11% in Q1 2026 to a low of 319.8% in Q2 2024.
  • The 5-year median for Operating Margin is 220.61% (2024), against an average of 213.48%.
  • Year-over-year, Operating Margin plummeted -16956bps in 2023 and then soared 21722bps in 2026.
  • Insmed's Operating Margin stood at 255.44% in 2022, then rose by 17bps to 213.01% in 2023, then dropped by -4bps to 220.61% in 2024, then surged by 45bps to 121.19% in 2025, then soared by 59bps to 50.11% in 2026.
  • Per Business Quant, the three most recent readings for INSM's Operating Margin are 50.11% (Q1 2026), 121.19% (Q4 2025), and 257.13% (Q3 2025).